title: Detection of kidney reactive antibodies at crossmatch in renal transplant recipients.
abstract: We have investigated retrospectively sera from 70 renal allograft recipients for the presence of antibodies binding to a preanastomosis biopsy of the donor kidney by an indirect immunoperoxidase technique. All recipients had a negative T cell lymphocytotoxic crossmatch. A positive immunoperoxidase crossmatch for kidney-reactive antibodies was seen in 13/70 (18.6%) recipients--6 reacting with endothelium, 4 with epithelium, and 3 with both cell types. Neither the presence of these antibodies nor their pattern of staining correlated with recipient graft outcome. Following transplantation endothelial reactive antibodies developed in 15/43 (35%) patients, whereas tubular epithelial antibodies occurred in 5/43 (12%). The antibodies were persistent and accompanied graft failure in 10/14 (71%) patients, while transient antibodies were only associated with graft failure in 2/12 (17%) recipients. Development of lymphocytotoxic antibodies did not correlate with the presence of renal reactive antibodies or eventual graft outcome. Smooth muscle and antinuclear antibodies in recipient sera prior to transplantation were associated with improved graft survival. Eluates of 8/14 rejected grafts confirmed the presence of renal reactive antibodies, with patterns of staining similar to those observed in recipient sera. Antibodies in 7/8 recipients were shown by absorption studies to have HLA class I and/or II specificity, the remaining recipient having proximal tubular brush border antibodies.
authors.affiliation: Regional Immunology Service, Southampton General Hospital, United Kingdom.
authors.forename: P R
authors.initials: PR
authors.lastname: Evans
authors.forename: L P
authors.initials: LP
authors.lastname: Trickett
authors.forename: A R
authors.initials: AR
authors.lastname: Gosney
authors.forename: E
authors.initials: E
authors.lastname: Hodges
authors.forename: S
authors.initials: S
authors.lastname: Shires
authors.forename: P J
authors.initials: PJ
authors.lastname: Wilson
authors.forename: A G
authors.initials: AG
authors.lastname: MacIver
authors.forename: B
authors.initials: B
authors.lastname: Gardner
authors.forename: M
authors.initials: M
authors.lastname: Slapak
authors.forename: J L
authors.initials: JL
authors.lastname: Smith
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D001706:Biopsy; D004727:Endothelium / Q000276:immunology; D004848:Epithelium / Q000276:immunology; D005260:Female; D006680:HLA Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis*; D006650:Histocompatibility Testing; D006801:Humans; D007124:Immunoenzyme Techniques; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000276:immunology; D009392:Nephrectomy; D011184:Postoperative Period
chemical_list: D000974:Antibodies, Antinuclear; D006680:HLA Antigens; D006684:HLA-DR Antigens